GREEN CROSS WellBeing Corporation (KOSDAQ:234690)
South Korea · Delayed Price · Currency is KRW 9,270.00
+170.00 (1.87%)
At close: Jan 23, 2026
GREEN CROSS WellBeing Market Cap
GREEN CROSS WellBeing has a market cap or net worth of 164.5 billion as of January 23, 2026. Its market cap has decreased by -9.60% in one year.
Market Cap
164.50B
Enterprise Value
229.89B
Revenue
151.06B
Ranking
n/a
PE Ratio
18.00
Stock Price
9,270.00
Market Cap Chart
Since October 14, 2019, GREEN CROSS WellBeing's market cap has decreased from 221.90B to 164.50B, a decrease of -25.87%. That is a compound annual growth rate of -4.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 164.50B | 1.42% |
| Dec 30, 2025 | 162.19B | -9.18% |
| Dec 30, 2024 | 178.59B | 23.74% |
| Dec 28, 2023 | 144.33B | -1.22% |
| Dec 29, 2022 | 146.10B | -18.92% |
| Dec 30, 2021 | 180.19B | -27.50% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 14, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Organoidsciences | 214.02B |
| Vivozon Pharmaceutical | 193.99B |
| Kyung Dong Pharmaceutical | 152.76B |
| PHARMARESEARCH BIO | 147.16B |
| DongKoo Bio & Pharma | 140.08B |
| KOREA PHARMA | 137.86B |
| OPTUS Pharmaceutical | 133.76B |
| Pharos iBio | 127.78B |